Reliance (RELIANCE IS) halts cell-making plan after failed bid for China tech, Bloomberg reports

Reliance's decision to halt its cell-making plan following an unsuccessful bid for Chinese technology signals potential strategic shifts or obstacles in its growth strategy.

Newsquawk StaffPublished On the live feed at 3 more headlines followed before this page went public
Newsquawk headlinesUTC

[MARKET UPDATE] US equity futures see another modest leg lower (ES -0.4%, NQ -0.5%) following comments from US President Trump and Fed Chair Powell; Debt futures, precious metals and JPY continue rising

US President Trump says "Iran is starting to cross it [Trump's red line]"

Reliance (RELIANCE IS) halts cell-making plan after failed bid for China tech, Bloomberg reports

US President Trump says we are going to have Greenland, one way or another

White House says it was displeased with Exxon’s (XOM) reaction; Officials hint that Exxon might be kept out with regards to Venezuela

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This development may raise concerns among investors regarding future innovation and expansion capabilities, affecting market sentiment around Reliance's stock and possibly drawing attention from peers who may see opportunities or challenges in the region.

Related headlines

The whole workspace, free to try.

Try it free